2017年欧洲心脏病学会冠状动脉疾病双重抗血小板治疗指南的变化与创新——综述
Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease-a review.
作者信息
Alber Hannes F, Huber Kurt
机构信息
Department of Internal Medicine and Cardiology, Landeskrankenhaus, Klagenfurt, Carynthia, Austria.
Karl Landsteiner Institute for Interdisciplinary Science, Rehabilitation Centre Münster, Münster, Tyrol, Austria.
出版信息
Wien Klin Wochenschr. 2018 Dec;130(23-24):694-697. doi: 10.1007/s00508-018-1357-5. Epub 2018 Jul 20.
Duration and compostion of dual antiplatelet therapy has been increasingly changed within the past few years as also indicated in the firmer ESC guidelines. The current manuscript summarizes the most important changes in dual antiplatelet therapy as shown by a recent ESC position paper and offers quick insight into these new developments.
正如欧洲心脏病学会（ESC）更严格的指南中所指出的那样，在过去几年中，双联抗血小板治疗的持续时间和组成也在不断变化。本手稿总结了欧洲心脏病学会最近一份立场文件中所示的双联抗血小板治疗的最重要变化，并对这些新进展提供了快速的见解。
Zotero 插件